Unique, practical knowledge for nurses responsible for daily management of patients with cardiovascular disease, diabetes and related conditions.

Topic: Cardi

Wednesday, 13 December 2017
An 18-year UK study in more than 24,000 subjects shows the benefits of exercise in elderly patients. The EPIC Norfolk prospective population study showed that any physical activity in the elderly is better than none at all for reducing cardiovascular risk.
Friday, 23 February 2018

This useful wall chart shows how just 5-10% weight loss improves important markers of cardiovascular health, including lipids, blood pressure, diabetes risk and inflammation.

Category: Back to Basics
Tuesday, 08 May 2018

This NHS Health Check overview shows the target age groups and risk factors assessed during the process. All these details should be recorded on the primary care record.  The overview highlights the risk assessment, lifestyle management, clinical assessment and risk management processes involved in the NHS Health Check.

Category: Back to Basics
Tuesday, 10 April 2018

Cardiovascular disease (CVD) is the leading cause of death in Ireland and diminishes quality of life and places a burden on health care services. There is little known about CVD with regard to nurses’ health in Ireland. The overall aim of this study was to assess the lifestyle of cardiac nurses working in an acute setting for the first time in Ireland. These findings may have implications for primary care nurses.

Category: Editorial
Thursday, 02 February 2017

A French observational study has found that use of a beta-blocker early after myocardial infarction (MI) (within 48 hours) is associated with a substantial reduction in 30-day mortality in people who do not have heart failure. However, continuing with beta-blockers was not associated with a significant reduction in mortality at 1 year.

Wednesday, 21 February 2018

In the first 15 months of its operation, Bradford’s Healthy Hearts campaign has significantly improved the cardiovascular health of local people, and saved an estimated £1.2 m for the clinical commissioning group.

Category: Editorial
Thursday, 23 June 2016

New data from the EMPA-REG OUTCOME and LEADER trials presented at the recent American Diabetes Association meeting show that the SGLT-2 inhibitor empagliflozin and the GLP-1 receptor analogue liraglutide significantly reduce cardiovascular mortality and cardiovascular events in high-risk type 2 diabetes patients.

Tuesday, 03 October 2017

Anti-inflammatory injections lower the risk of cardiovascular disease in patients with previous myocardial infarction independently of lowering lipid levels, in a recent study reported in the New England Journal of Medicine.

Article search and filter